Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.

Background: Temporal trends in prostate cancer incidence and death rates have been attributed to changing patterns of screening and improved treatment (mortality only), among other factors. This study evaluated contemporary national-level trends and their relations with prostate-specific antigen (PSA) testing prevalence and explored trends in incidence according to disease characteristics with stage-specific, delay-adjusted rates.

Methods: Joinpoint regression was used to examine changes in delay-adjusted prostate cancer incidence rates from population-based US cancer registries from 2000 to 2014 by age categories, race, and disease characteristics, including stage, PSA, Gleason score, and clinical extension.

Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.

Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates on cancer occurrence and trends in the United States.

Methods: Incidence data were obtained from the CDC-funded and NCI-funded population-based cancer registry programs and compiled by NAACCR. Data on cancer deaths were obtained from the National Center for Health Statistics National Vital Statistics System.

Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.

Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates on cancer occurrence and trends in the United States. This Annual Report highlights survival rates. Data were from the CDC- and NCI-funded population-based cancer registry programs and compiled by NAACCR.

Unusual metal-coordinated zwitterionic P-C-N-C-N-C phosphido adducts.

Rare examples of homodinuclear zwitterionic Pd(II) and Pt(II) complexes with bridging, two-coordinate P{cyclo-CH(2)N(R)CHN(R)CH(2)} ligands (R = 4-FC(6)H(4)CH(2), C(6)H(5)CH(2)) have been characterized by single-crystal X-ray diffraction using synchrotron radiation. Short N-C distances and enlarged N-C-N bond angles support electron delocalization in the central N-C-N backbone.

Intramolecular hydrogen-bonded tertiary phosphines as 1,3,5-triaza-7-phosphaadamantane (PTA) analogues.

New cationic trialkylphosphines [P(CH(2)NH(2)R){CH(2)N(R)CH(2)N(R)CH(2)}](+) (R = C(6)H(5)CH(2), a; 4-FC(6)H(4)CH(2), b), as their Cl(-) (1a, 1b), SbF(6)(-) (2a, 2b), and PF(6)(-) (3a, 3b) salts, are described. The phosphine framework is conformationally locked, in the solid state, through pairs of intramolecular N-H..

A novel fluorene-containing kappa(4)-P(2)N(2)-tetradentate platinum(II) complex.

Base induced P,N-chelation, C-C coupling and methylene C-H deprotonation affords an unusual fluorene containing square-planar Pt(II) complex Pt(kappa4-P2N2-Ph2PCH=NNCC12H8)2 which has been isolated and structurally characterised.

Method to assess identifiability in electronic data files.

The authors developed the Record Uniqueness (RU) software program to assess electronic data files for risk of confidentiality breach based on unique combinations of key variables. The underlying methodology utilized by the RU program generates a frequency distribution for every variable selected for analysis and for all combinations of the variables selected. In addition, the program provides the regression coefficient that designates the relative contribution of each variable to the unique records on the data file.